Page 5 - James Xue News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CANbridge Announces Encouraging Development in Maralixibat/LIVMARLI in Rare Liver Disease

CANbridge Announces Encouraging Development in Maralixibat/LIVMARLI in Rare Liver Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

James xueChris brinzeyPlanet communicationsChina national medical products administrationMass business wire canbridge pharmaceuticals incBoao lecheng international medical tourism pilot zoneUniversity of washington school medicineCanbridge pharmaceuticals incMirum pharmaceuticals incUmass chan medical schoolPositive topline phaseGreater chinaMirum pharmaceuticalsDisease listPilot implementation policyBreakthrough therapy designation

CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September

CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJames xueChris brinzeyMorgan stanleyMass business wire canbridge pharmaceuticals incUniversity of washington school medicineCanbridge pharmaceuticals incPlanet communicationsUmass chan medical schoolWall streetAnnual global healthcare conferenceGlobal healthcare shanghai conferenceWuxi biologicsChan medical schoolWashington school

CANbridge doses first subject in Phase I/II Gaucher disease therapy trial

CANbridge doses first subject in Phase I/II Gaucher disease therapy trial
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

James xueChina alliance for rare diseaseContract research organisation for clinical trialsSaas platform decentralizing clinical research at scaleUnion medical college hospitalCanbridge pharmaceuticalsNational collaborative network for the diagnosisWuxi biologicsChina allianceRare diseasePeking union medical college hospitalNational collaborative networkRare diseasesResearch organisationRegulatory consultation

First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China

Press release content from Business Wire. The AP news staff was not involved in its creation.

South koreaUnited statesJames xueChris brinzeyChina alliance for rare diseaseUniversity of washington school medicineCanbridge pharmaceuticals incUnion medical college hospitalPlanet communicationsUmass chan medical schoolNational collaborative network for the diagnosisBing hanChief physicianPeking union medical college hospitalWuxi biologicsChina alliance

First Patient Dosed in CAN108 (Maralixibat) EMBARK Phase 2 Study in Biliary Atresia in China

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesJames xueChris brinzeyDrug administrationPlanet communicationsChildren hospital of capital institute pediatricsUniversity of washington school medicineCanbridge pharmaceuticals incMirum pharmaceuticals incCanbridge pharmaceuticalsUmass chan medical schoolCapital instituteMirum pharmaceuticalsPilot implementation policyMirum pharmaceuticals sponsoredNorth america